MedTrace Logo

Grasp-Release Assessment of a Networked Neuroprosthesis Device

NCT05863754 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2025-12-19

No results posted yet for this study

Summary

The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

Conditions

  • Spinal Cord Injury at C5-C7 Level
  • Spinal Cord Injuries
  • Spinal Cord Injury Cervical

Interventions

DEVICE

Networked Neuroprosthesis Device

The Networked Neuroprosthesis Device is an implantable, configurable neuromodulation platform that provides functional movement by the coordinated activation of peripheral neural pathways activating innervated paralyzed muscles, and sensing of physiological signals.

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Case Western Reserve University

    collaborator OTHER

  • MetroHealth Medical Center

    lead OTHER

Principal Investigators

  • Anne Bryden, PhD, OTR/L · MetroHealth Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-23
Primary Completion
2027-12-01
Completion
2028-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863754 on ClinicalTrials.gov